Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care
Vasoplegic syndrome (VS) is a common complication following cardiovascular surgery with cardiopulmonary bypass (CPB), and its incidence varies from 5 to 44%. It is defined as a distributive form of shock due to a significant drop in vascular resistance after CPB. Risk factors of VS include heart fai...
Main Authors: | Zied Ltaief, Nawfel Ben-Hamouda, Valentina Rancati, Ziyad Gunga, Carlo Marcucci, Matthias Kirsch, Lucas Liaudet |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/21/6407 |
Similar Items
-
Methylene blue compared to norepinephrine in the management of vasoplegic syndrome in pediatric patients after cardiopulmonary bypass: a randomized contr
by: Raafat Abdelazim, et al.
Published: (2016-07-01) -
Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study
by: Othmar Kofler, et al.
Published: (2022-02-01) -
Efficacy of methylene blue for on vasoplegic syndrome
by: Mohsen akhondi, et al.
Published: (2016-04-01) -
Vasoplegic syndrome after cardiopulmonary bypass for paravalvular leak of mitral bioprosthesis
by: Yu-Xuan Jiang, et al.
Published: (2023-01-01) -
Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
by: Laurence W. Busse, et al.
Published: (2020-02-01)